Beijing FortuneStar

Beijing FortuneStar is a specialized healthcare company headquartered in Beijing, China, with a dual focus on advanced medical devices and biopharmaceuticals. The company is widely recognized for its leadership in stereotactic radiotherapy, particularly through its development of the proprietary FortuneStar rotating Gamma Knife systems for treating intracranial and extracranial tumors. Beyond its medical technology division, Beijing FortuneStar operates a pharmaceutical arm that produces essential biologics, including recombinant human interleukin-11 (rhIL-11) for the treatment of chemotherapy-induced thrombocytopenia. With a history dating back to the early 1990s, the company provides integrated oncology solutions, combining diagnostic imaging, treatment planning, and therapeutic delivery systems. Beijing FortuneStar maintains a strong presence in the Chinese domestic market and has expanded its reach to international healthcare providers.